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Abstract. 
 
Collagen XVIII (c18) is a triple helical endo-
thelial/epithelial basement membrane protein whose non-
collagenous (NC)1 region trimerizes a COOH-terminal
endostatin (ES) domain conserved in vertebrates,
 
Caenorhabditis elegans
 
 and 
 
Drosophila
 
. Here, the c18
NC1 domain functioned as a motility-inducing factor
regulating the extracellular matrix (ECM)-dependent
morphogenesis of endothelial and other cell types. This
motogenic activity required ES domain oligomerization,
was dependent on rac, cdc42, and mitogen-activated pro-
tein kinase, and exhibited functional distinction from the
archetypal motogenic scatter factors hepatocyte growth
factor and macrophage stimulatory protein. The mo-
tility-inducing and mitogen-activated protein kinase–
stimulating activities of c18 NC1 were blocked by its
physiologic cleavage product ES monomer, consistent
with a proteolysis-dependent negative feedback mecha-
nism. These data indicate that the collagen XVIII NC1
region encodes a motogen strictly requiring ES domain
oligomerization and suggest a previously unsuspected
mechanism for ECM regulation of motility and mor-
phogenesis.
Key words: collagen XVIII • endostatin • motility •
morphogenesis • extracellular matrix
 
Introduction
 
The extracellular matrix (ECM)
 
1
 
 consists of a protein
and carbohydrate substratum comprising the intercellular
space not occupied by cell–cell adhesive complexes. Far
from a passive support, the ECM has been linked to multi-
ple activities, including structural or adhesive support,
growth factor sequestration, and regulation of cell growth,
differentiation, and morphogenesis. Proteinaceous ECM
components include fibronectin, laminins, vitronectin, and
collagens, many of which bind to various 
 
ab
 
 integrins with
transduction of intracellular signals (Giancotti and Ruo-
slahti, 1999; Streuli, 1999).
The collagens comprise a major category of intrinsic
ECM proteins, encompassing 
 
z
 
20 family members united
by triple helical structure and Gly-Xaa-Yaa repeats. Many
collagen functions have been deduced from mutant phe-
notypes in humans or homozygous knockout mice, in-
cluding osteogenesis imperfecta, Alport syndrome, Eh-
lers-Danlos syndrome, and several chondrodysplasias
(Prockop and Kivirikko, 1995). On the other hand, col-
lagens are ligands for transmembrane signaling proteins
such as the 
 
a
 
1
 
b
 
1, 
 
a
 
2
 
b
 
1, and 
 
a
 
10
 
b
 
1 integrins and discoidin
domain receptor (DDR) transmembrane tyrosine kinases
which activate downstream responses such as tyrosine
phosphorylation and activation of focal adhesion kinase
and phospholipase C
 
g
 
 (Vogel, 1999).
The multiplexin subclass of collagens, represented by
collagens XV and XVIII (c15, c18), are characterized by
multiple interrupted triple helical regions and a unique
COOH-terminal endostatin (ES) domain (discussed
below) (Oh et al., 1994; Rehn and Pihlajaniemi, 1994).
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Collagen XV/XVIII exhibits striking evolutionary conser-
vation in vertebrates, 
 
Caenorhabditis elegans
 
 and 
 
Dro-
sophila
 
, with sequencing of the 
 
C. elegans
 
 and 
 
Drosophila
 
genomes revealing the presence of only type IV and type
XV/XVIII verterbrate collagens, as described in this issue
by Ackley et al. (2001) and in recent reviews (Hutter et al.,
2000; Hynes and Zhao, 2000). The 
 
C. elegans 
 
and 
 
Dro-
sophila
 
 homologues more closely resemble collagen XVIII
than collagen XV, based on isoform structure and motifs
in a putative heparin-binding domain (Sasaki et al., 2000;
Ackley et al., 2001).
Collagen XVIII (c18) is a ubiquitous component of en-
dothelial and epithelial basement membranes (Muragaki
et al., 1995; Musso et al., 1998; Saarela et al., 1998) and has
been identified recently as the genetic lesion in Knobloch
syndrome, an autosomal recessive condition characterized
by scalp and/or neural tube closure deficits and retinal de-
generation (Sertie et al., 2000). In addition to triple helical
repeats, the c18 gene contains an alternative exon encod-
ing a domain homologous to the 
 
Drosophila
 
 tissue polarity
gene 
 
frizzled
 
 (see Fig. 1 A) (Rehn et al., 1998; Saarela et
al., 1998). The 38-kD COOH-terminal extent of c18 is
nontriple helical and is designated noncollagenous (NC)1
domain. Within NC1, a nontriple helical trimerization do-
main redundantly trimerizes the globular COOH-terminal
20-kD ES domains (see Fig. 1 A) (Sasaki et al., 1998). The
NC1 domain represents a predominant tissue form of c18
in numerous tissues, including liver and lung, and is partic-
ularly amenable to biochemical study, since it is easily pro-
duced as soluble recombinant protein (Sasaki et al., 1998)
as opposed to full-length collagen XVIII.
The ES domain within c18 NC1 has been reported to in-
hibit endothelial proliferation and migration, induce en-
dothelial apoptosis, and inhibit tumor growth (O’Reilly et
al., 1997; Dhanabal et al., 1999a,b; Yamaguchi et al., 1999;
Dixelius et al., 2000). In vertebrates, the ES domain is only
represented in collagen XVIII and the related collagen
XV (Muragaki et al., 1994; Sasaki et al., 1998) and con-
served (45% amino acid identity) in 
 
C. elegans
 
 and 
 
Dro-
sophila 
 
collagen XVIII homologues. The “hinge” region
between the trimerization domain and the ES domain
(Fig. 1 A) is cleaved by elastase and/or cathepsin L to re-
lease free ES from c18 (Sasaki et al., 1998; Wen et al.,
1999; Felbor et al., 2000). It is relevant to the present stud-
ies that physiologic proteolysis in the hinge region con-
verts ES from an obligately trimerized form into a mono-
meric form, as was initially purified (O’Reilly et al., 1997).
In the current work, we describe that the collagen XVIII
NC1 domain regulates ECM-dependent motility and mor-
phogenesis of both endothelial and nonendothelial cells in
a manner strictly requiring ES domain oligomerization
and the activities of rac, cdc42, and the mitogen-activated
protein (MAP) kinase (MAPK) pathway. We additionally
demonstrate that the motogenic and morphogenic proper-
ties of the c18 NC1 trimer are distinct from and in fact an-
tagonized by its physiologic cleavage product ES mono-
mer, and that the c18 NC1 trimer is inhibited by ES
monomer in a potential negative autoregulatory loop.
Ackley et al. (2001) in this issue describe mechanistically
similar findings in which the 
 
C. elegans
 
 collagen XVIII ho-
mologue CLE-1 promotes neuronal motility through its
trimerization-competent NC1 domain, whereas CLE-1 ES
monomers behave as dominant negative (DN) alleles
 
which inhibit motility induced by wild-type CLE-1. These
data implicate domains of the evolutionarily conserved
type XVIII collagen in the regulation of cell motility and
establish a previously unsuspected mechanism for ECM
regulation of motility and morphogenesis.
 
Materials and Methods
 
Expression of Recombinant Proteins
 
Human Fc-human ES proteins, containing the 184–amino acid COOH-
terminal ES domain from HSHRDF through SFMTASK, were purified
from conditioned medium of stable myeloma transfectants and human ES
monomer produced by subsequent enterokinase (EK) cleavage as de-
scribed previously (Ding et al., 1998; Lo et al., 1998). Disulfide-bonded
human ES dimer was produced similarly except that the expression vector
pdCs-Fc(D4K)-huEndo was mutated Q7
 
®
 
C7 to produce pdCs-Fc(D4K)-
huEndo(C7).
The human collagen XVIII NC1 was produced by PCR with primers
5
 
9
 
-GATC GGCC CAGCC GGCC CAT CAT CAC CAT CAC CAT
GAC GAT GAC GAT AAG TCA GGG CAG GTG AGG CTC TGG
GCT ACA CGC CAG G-3
 
9
 
 and 5
 
9
 
-GATC GGATCC CTA CTT GGA
GGC AGT CAT GAA GC-3
 
9
 
 using human collagen XVIII cDNA (a gift
from B. Olsen, Harvard Medical School, Boston, MA) as template ampli-
fying SGQVRL through the COOH terminus. Murine collagen XVIII
NC1 was produced identically using the primers 5
 
9
 
-GATC GGCC
CAGCC GGCC CAT CAT CAC CAT CAC CAT GAC GAT GAC
GAT AAG GCT GGG CAG GTG AGG ATC TGG GCC ACA TAC
C-3
 
9
 
 and 5
 
9
 
-GATC GGATCC CTA TTT GGA GAA AGA GGT CAT
GAA GC-3
 
9
 
 from the template mc3b (a gift from B. Olsen), amplifying
AGQVRI through the COOH terminus. Murine collagen XV NC1 was
amplified from mc15 cDNA (a gift from T. Pihlajaniemi, University of
Oulu, Oulu, Finland) with 5
 
9
 
-GATC GGCC CAGCC GGCC CAT CAT
CAC CAT CAC CAT GAC GAT GAC GAT AAG GTC ACA GGC
CTC AGC GAC ATG GGT GAC ATG CTA CAG-3
 
9
 
 and reverse
primer 5
 
9
 
-GATC GGATCC TCA CTT CCT AGT GTC TGT CAT GAA
AC-3
 
9
 
, amplifying LSDM through the COOH terminus. The PCR prod-
ucts hNC1(c18), mNC1(c18), or mNC1(c15) were cloned SfiI-BamHI into
pSecTag2A (Invitrogen) in frame with the IgK signal peptide, transfected
into 293T cells by calcium phosphate, and conditioned medium-purified
over Ni-agarose using the NH
 
2
 
-terminal 6
 
3 
 
His tag embedded by PCR.
Two versions of the ES domain of murine collagen 15 were amplified
from mc15 cDNA (a gift from T. Pihlajaniemi) by PCR using the forward
primers 5
 
9
 
-GATC C CCG GGT TCA GGG GAT GAC GAT GAC GAT
AAG TTA AGT GCC AAC TAT GAG AGG CCT G-3
 
9
 
 or 5
 
9
 
-GATC C
CCG GGT TCA GGG GAT GAC GAT GAC GAT AAG CCT GTT
CTG CAC CTG GTT GCT CTG-3
 
9
 
 and the reverse primer 5
 
9
 
-GATC
CTC GAG TCA CTT CCT AGT GTC TGT CAT GAA AC-3
 
9
 
, amplify-
ing LSANYER or PVLHLVA through the COOH terminus. The result-
ant fragments were ligated XmaI-XhoI into the expression vector pdCs
(Lexigen) in frame with a 5
 
9
 
 coding region for murine IgG2
 
a
 
 Fc, and Fc-
ES(c15) was purified from conditioned medium of stable myeloma trans-
fectants using protein A–Sepharose. No differences were observed using
either of the two Fc-ES(c15) recombinant proteins.
 
SDS-PAGE Analysis of Purified Recombinant Human 
c18 Fragments
 
Human ES monomer from Fc-ES EK cleavage or human ES dimer from
EK cleavage of Fc-ES(Q7
 
®
 
C7) (analyzed by SDS-PAGE at 5 
 
m
 
g/lane un-
der nonreducing [without DTT] or reducing [with DTT] conditions). The
doublet observed with hES monomer represents a four–amino acid NH
 
2
 
-
terminal cleavage. Human NC1 ES trimer (40 
 
m
 
g) with or without ethyl-
ene glycol bis-succinimidyl succinate (EGS) cross-linking (see Materials
and Methods) was analyzed by SDS-PAGE.
 
Cell Culture and Lines
 
Human umbilical vein endothelial cells (HUVECs) and human dermal
microvascular endothelial cells were purchased from Clonetics and grown
in EBM containing EGM-2-MV supplements (vascular endothelial
growth factor [VEGF], hepatocyte growth factor [HGF], and hydrocorti-
sone). 293 cells and MDCK cells were obtained from American Type Cul-
ture Collection and grown in DME with 10% FCS and 
 
L
 
-glutamine. PC12
cells were a gift from M. Greenberg (Children’s Hospital, Boston, MA) 
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and grown in DME with 10% horse serum, 5% FCS, penicillin streptomy-
cin, and 
 
L
 
-glutamine on collagen I–coated dishes.
 
Matrigel Tube Formation Assay
 
Matrigel, an ECM preparation from the Engelbreth-Holm-Swarm tumor,
was purchased from Collaborative/BD PharMingen. Multiwell dishes (24-
well) were coated with 250 
 
m
 
l Matrigel at 4
 
8
 
C and incubated at 37
 
8
 
C for 20
min followed by seeding with HUVECs, human dermal microvascular en-
dothelial cells, or other cell types in 1 ml complete medium at 50,000 cells/
ml. Recombinant ES monomer, dimer, NC1, or Fc-ES fusion proteins
were added either at plating or after 16 h of tube formation. Molecular
masses used for calculation of molarity were as follows: ES monomer (20
kD), ES dimer (40 kD 
 
5 
 
20 
 
3 
 
2), NC1(c18) trimer (114 kD 
 
5
 
 38 
 
3 
 
3), and
NC1(c15) trimer (93 kD 
 
5
 
 31 
 
3
 
 3). Cells were photographed under
phase–contrast and images were imported into Adobe Photoshop
 
®
 
 or
Canvas 5. Where relevant, cells were preincubated with ES monomer (30
min) or 
 
Clostridium difficile
 
 toxin B (50 ng/ml, 4 h) before addition of
hNC1 or ES dimer. HGF (R&D Systems) was used at 50 ng/ml. Tubes
were quantitated by manual counting in triplicate of low power fields
(40
 
3
 
). Phalloidin-FITC staining for actin was performed after paraform-
aldehyde fixation using confocal microscopy.
 
Assay for MAPK Activation
 
HUVECs on Matrigel for 16 h were preincubated for 60 min with or with-
out PD98056 or SB203580 (50 
 
m
 
M) (Calbiochem), followed by treatment
with hES monomer (3,000 nM), hES dimer (50 nM), or c18 NC1 (50 nM).
Cells were washed twice in Hepes-buffered saline and lysed with SDS-
PAGE sample buffer with 
 
b
 
-mercaptoethanol. Lysates were analyzed by
SDS-PAGE and Western blotting using anti–phospho-MAPK or extracel-
lular signal–regulated kinase (ERK)2 antisera (New England Biolabs,
Inc.). Fold activation was calculated by densitometry of anti–phospho-
 
MAPK Western blots, assigning activity of unstimulated extracts as one-
fold. No significant differences were observed between untreated and
monomer-treated cells.
 
Adenoviral Infection of Endothelial Tubules
 
Recombinant adenoviruses encoding a chimeric tetracycline repressor/
VP16 transactivator domain (Ad–tTA) or encoding DN alleles of rac or
rho under the control of a minimal cytomegalovirus promoter driven by
seven tetracycline operator sites have been described previously (Kalman
et al., 1999). The construction of Ad-cdc42DN will be described else-
where. HUVECs were infected at the time of plating on Matrigel in com-
plete medium with Ad-tTA at a multiplicity of infection of 1:1,000. After
12 h, tubule formation was identical to uninfected cells (data not shown),
and tubules were infected as appropriate with Ad-racDN, Ad-rhoDN, or
Ad-cdc42DN for 4 h at a multiplicity of infection of 1:2,000. Subsequently,
cells were treated with hES dimer (75 nM) for 24 h and photographed un-
der phase–contrast. All incubations were in the absence of tetracycline to
allow for maximal transactivation of the Ad-DN constructs. Inhibition of
motility was not observed with either Ad-tTA or Ad-DN viruses alone
(data not shown).
 
Online Supplemental Material
 
HUVECs were plated into Matrigel-coated 2-well slide chambers as
above, and tubes were allowed to form for 16 h. Human ES dimer (50 nM)
was added at the start of videomicroscopy (see Fig. 3 C; video available
at http://www.jcb.org/cgi/content/full/152/6/1233/DC1. The total video
length is 12 h and was captured in a total of 360 frames at 30 frames per
hour. Images were captured on a phase–contrast microscope at 200
 
3
 
 mag-
nification, saved to disk, and converted to avi format using Image Pro Plus
software. The video was converted to Quicktime
 
®
 
 4 format using Vid4Win
2 QT software (shareware). 
Figure 1. Inhibition of in vitro endothelial tube assembly by collagen XVIII NC1. (A) Topology of collagen XVIII. Signal peptide,
triple helical collagenous repeats, NC1 domain, and a protease-sensitive “hinge” region interposed within the trimerization and ES
motifs are indicated. Dotted line indicates alternative splice which occurs in nonhepatic tissues and removes the frizzled homology
domain. (B) Production of recombinant c18 NC1. Human c18 NC1 purified from supernatant of stably transfected 293T cells was ana-
lyzed by SDS-PAGE with or without EGS cross-linking. Oligomeric forms corresponding to NC1 trimer at z114 kD (38 3 3) and 76-kD
species from incomplete cross-linking (38 3 2) are indicated. (C) Recombinant c18 NC1 inhibits in vitro endothelial tube formation.
HUVECs were plated on Matrigel in the absence (untreated) or presence of murine or human c18 NC1 at 50 nM and photographed
under phase–contrast after 16 h (magnification 340). A complete lack of tubular structures and a dispersed cell phenotype are apparent in
the NC1-treated wells. (D) Dose-dependent inhibition of endothelial tube formation by recombinant c18 NC1. Indicated amounts of hu-
man or mouse c18 NC1 were added at the time of HUVEC seeding onto Matrigel-covered wells. Tubular structures were quantitated by
manual counting of low power fields after 16 h and percent inhibition was expressed using untreated wells as 100%. 
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Results
 
Inhibition of Endothelial Tube Formation by the 
Collagen XVIII NC1 Domain
 
To evaluate potential functions of collagen XVIII, the sol-
uble c18 NC1 domain was produced from conditioned me-
dium of transfected 293T cells and migrated at 38 kD upon
SDS-PAGE (Fig 1 B, left lane) in agreement with pub-
lished results (Sasaki et al., 1998). Consistent with trimer-
ization, this recombinant protein produced an 
 
z
 
114-kD
species (38 
 
3
 
 3) upon EGS cross-linking (Fig. 1 B, right
lane), confirming previous reports documenting an NH
 
2
 
-
terminal trimerization domain, migration as a trimer upon
gel filtration, and trimeric appearance upon electron mi-
croscopy (Sasaki et al., 1998).
We explored the behavior of c18 NC1 in an in vitro mor-
phogenesis assay during which endothelial cells plated on
ECM preparations, such as Matrigel, spontaneously aggre-
gate and assemble into densely multicellular capillary-like
tubular structures (Folkman and Haudenschild, 1980;
Grant et al., 1991). Although when used with endothelial
cells, this assay recapitulates numerous aspects of angio-
genesis, including cellular migration, differentiation, and
metalloproteinase activation (Grant et al., 1991), nonen-
dothelial cells such as fibroblasts can undergo similar mor-
phologic changes, and thus this assay may best reflect
ECM-induced changes in cell adhesion and morphogene-
sis. Human or murine c18 NC1 treatment at the time of
HUVEC plating on Matrigel strongly inhibited assembly
into tubular structures, with cells remaining dispersed and
exhibiting a morphology resembling cells on plastic rather
than aggregating into characteristic capillary-like tubes
(Fig. 1 C). Quantitation of tubular structures by light mi-
croscopy revealed a dose-dependent effect with an IC
 
50
 
 of
 
z
 
10 nM (Fig. 1 D). Stimulation of proliferation was not
detected by BrdU staining or [
 
3
 
H]thymidine incorporation
during this time interval, nor was stimulation of cell death
detected after recovery of cells from Matrigel and trypan
blue staining (data not shown). Identical results were ob-
tained with primary cultures of human microvascular, um-
bilical artery, or pulmonary artery endothelial cells, and
morphological effects were not observed on tissue culture
plastic or on gels of purified matrix proteins such as col-
lagen I or fibrin (data not shown).
 
Induction of Cellular Motility by the Collagen XVIII 
NC1 Domain
 
The dispersed phenotype of HUVECs treated with c18
NC1 prompted investigation of the effects of this protein
on preestablished endothelial tubules. Strikingly, when
applied to HUVEC tubules, recombinant c18 NC1 stimu-
lated active cell motility with migration of cells away
from the structures easily observable by 2 h of treatment
(Fig. 2 A, top). Phase–contrast microscopy revealed abun-
Figure 2. Stimulation of endothelial cell motility by collagen XVIII NC1. (A) Rapid induction of motility by human c18 NC1. HUVECs
were plated on Matrigel for 16 h and allowed to form tubular structures, followed by recombinant human c18 NC1 treatment (50 nM)
for 2 h. Top, phase–contrast microscopy (magnification 3200); bottom, confocal microscopy. Cells treated as above were stained with
phalloidin-FITC to stain filamentous actin and photographed under confocal microscopy. NC1-treated cells exhibit prominent cell mi-
gration with formation of stress fibers, filopodia, and lamellipodia. (B) Migration of HUVECs from preestablished tubules is stimulated
by c18 NC1. HUVECs were plated on Matrigel for 16 h and identical fields were photographed under phase–contrast before (0 h) and
after (8 h) stimulation by recombinant human c18 NC1 (50 nM) (magnification 340). 
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dant structures resembling filopodia and lamellipodia,
which were confirmed upon confocal microscopy for
phalloidin-FITC reactivity (Fig. 2 A, bottom) and by
videomicroscopy (see below). This cellular migration was
more pronounced with time, with cells becoming pro-
gressively more dispersed and acquiring a “scattered”
phenotype (Fig. 2 B). Preformed tubules were increas-
ingly refractory to dispersion after 16–24 h and moto-
Figure 3. ES domain oligomerization is necessary and sufficient for c18-induced motility. (A) Schematic of synthesis of ES domain
monomer and dimer. Cleavage of an Fc-ES domain fusion produces free ES monomer. In contrast, cleavage of Fc-ES(Q7®C7) pro-
duces an ES domain dimer because of disulfide bond formation between adjacent C7 residues. (B) Nonreducing and reducing SDS-
PAGE of purified recombinant human ES monomer and dimer. Migration shift from 40 to 20 kD is noted for ES dimer but not ES
monomer upon disulfide reduction with DTT. (C) ES dimer but not ES monomer stimulates migration of HUVECs from pre-formed
tubules on Matrigel. HUVECs were plated on Matrigel and allowed to form tubes for 16 h, followed by stimulation with ES monomer
(3,000 nM) or ES dimer (50 nM) for the indicated times. Representative fields were photographed under phase–contrast (magnification
3200). (D) Dose response to recombinant human ES dimer. HUVECs were plated on Matrigel in the presence of hES dimer, and after
16 h tubular structures were quantitated by manual counting of central fields and percentage of maximal tube formation was calculated.
(E) Induction of motility by Fc-ES fusions which dimerize the ES domain. Preformed HUVEC tubules were treated with Fc-mES(c18)
(40 nM), Fc (3,000 nM), or mES(c18) (3,000 nM) and photographed after 30 h (magnification 340). (F) Summary of motogenic activity
of monomeric, dimeric, and trimeric ES domain derivatives. 
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genic activity was not observed against HUVECs plated
on plastic (data not shown).
 
ES Domain Oligomerization Is Necessary and Sufficient 
for Motogenic Activity
 
To localize the motogenic region of c18 NC1, a series of
derivative proteins were constructed. The potential in-
volvement of the ES domain comprising the COOH-ter-
minal 184 amino acids of NC1 (Sasaki et al., 1998) was ex-
amined with an Fc-ES domain fusion protein (Fc-ES)
containing an NH
 
2
 
-terminal human IgG1 Fc fragment, an
interposed EK cleavage site, and a COOH-terminal ES
domain (Fig. 3 A). EK cleavage of Fc-ES allowed large
scale production of ES domains (Fig. 3 A) whose composi-
tion and monomeric nature were confirmed by denaturing
and nondenaturing SDS-PAGE (Fig. 3 B, left), and by gel
 
filtration and mass spectrometry (data not shown). Human
and murine ES monomers thus produced were completely
inactive at eliciting motility at 3,000 nM, the highest con-
centration tested (Fig. 3 C, top), as were murine and hu-
man ES monomers produced in baculovirus or yeast (data
not shown).
Since the ES domain is physiologically trimerized in the
context of collagen XVIII and NC1 (Sasaki et al., 1998)
(Fig. 1 A), we evaluated whether c18 motogenic activity re-
quired ES domain oligomerization by constructing an arti-
ficial ES domain dimer. The ES crystal structure predicts a
dimer in which glutamine-7 residues in adjacent subunits
are in close proximity (Ding et al., 1998). Fusion of heter-
ologous proteins to an antibody Fc fragment produces ob-
ligate dimerization via disulfide bonds in the Fc region (Lo
et al., 1998). Mutation of ES glutamine-7 residue to cys-
Figure 4. Oligomerized collagen XV ES domains do not exhibit motogenic activity. HUVECs were plated on Matrigel in the presence
of mNC1(c18) (50 nM), mNC1(c15) (100 nM), or Fc-mES(c15) (250 nM) and photographed after 20 h. Identical results were obtained
upon application of factors to preformed tubules.
Figure 5. Motile response of nonendothelial cell types to c18 derivatives. PC12 and 293T cells were cultured with hES monomer (3,000
nM), hES dimer (25 nM), or hNC1 (50 nM) on Matrigel for 16 h and photographed under phase–contrast (magnification 3200 [bottom]). 
Kuo et al.
 
 Collagen XVIII Motogenic Activity
 
1239
 
teine in the context of Fc-ES fortuitously produced a novel
intermolecular disulfide bond between adjacent ES mole-
cules (Fig. 3 A, bottom). EK cleavage of this mutant Fc-
ES(Q
 
®
 
C) then liberated free ES dimer migrating at 40
and 20 kD under nonreducing and reducing conditions, re-
spectively (Fig. 3, A and B, right). This ES domain dimer
potently reproduced the inhibitory activity of the Fc-ES
fusion or NC1 with half-maximal inhibition at 
 
z
 
10 nM
(Fig. 3, C and D). Videomicroscopy of endothelial tubules
treated with ES dimer confirmed rapid (
 
,
 
2 h) stimulation
of motility, formation of filopodia and lamellipodia, and
virtual absence of cell division (see video at http://
www.jcb.org/cgi/content/full/152/6/1233/DC1), paralleling
findings with c18 NC1 (Figs. 1 and 2). The activity of the
ES dimer (10 nM) versus the inactivity of the ES monomer
(
 
.
 
3,000 nM, the highest concentration tested) indicated
that the active region of c18 NC1 localized to the ES do-
main and that oligomerization of the ES domain was both
necessary and sufficient for motogenic activity. Further
consistent with a requirement for oligomerization, the
Fc-ES (wt) protein, in which the ES domain is obligately
dimerized, potently stimulated motility from preformed
HUVEC tubules, whereas either Fc or ES derived from
EK cleavage of Fc-ES was ineffective (Fig. 3 E). Identical
stimulation of motility was observed with Fc-ES(Q
 
®
 
C)
(data not shown). The activity of c18 derivatives in which
the ES domain is oligomerized, versus the inactivity of ES
monomers is summarized (Fig. 3 F).
 
Oligomerized Collagen XV ES Domains Do Not Exhibit 
Motogenic Activity
 
Collagen XVIII and collagen XV define the multiplexin
subclass of collagens, characterized by multiple interrup-
 
tions in the triple helical region and a globular COOH-ter-
minal ES domain. The NC1 domains of both c18 and c15
trimerize (Sasaki et al., 2000), and the cognate ES domains
exhibit 60% amino acid identity (Muragaki et al., 1994; Oh
et al., 1994; Rehn and Pihlajaniemi, 1994). Despite these
similarities, the c18 and c15 NC1 domains differ strikingly
in their abilities to associate with heparin and zinc, in affin-
ity for matrix components exhibited by monomers versus
trimers, and a shorter “hinge” region in the NC1 domain in
c15 (Sasaki et al., 2000). We produced recombinant c15
NC1 domains from the conditioned medium of transfected
293T cells but observed complete lack of inhibition of HU-
VEC tube formation on Matrigel at 100 nM, the highest
concentration tested (Fig. 4). Similarly, dimeric Fc fusion
proteins containing Fc at the NH
 
2
 
 terminus and the col-
lagen XV ES domain at the COOH terminus (Fc-ES[c15])
neither scattered endothelial tubules (Fig. 4) nor antago-
nized the effects of Fc-ES(c18) at 30-fold molar excess
(data not shown). Under these conditions, the motogenic
properties of ES domain oligomers are thus highly specific
for c18 and not c15, in accordance with divergent structural
and functional properties (Muragaki et al., 1994; Oh et al.,
1994; Rehn and Pihlajaniemi, 1994; Sasaki et al., 2000).
Collagen XVIII NC1 Motogenic Activity Is Not Specific 
for Endothelial Cells
The growth-inhibitory, migration-inhibitory, or apoptosis-
stimulatory activities of the monomeric ES domain have
been reported to be selective for endothelial cells and not
other cell types (O’Reilly et al., 1997; Dhanabal et al.,
1999a,b). On the other hand, the precursor molecule c18 is
not only expressed in vascular basement membranes, but
also in most epithelial membranes such as liver, lung, and
Figure 6. Comparison of c18 and HGF motogenic activities. HUVEC tubules on Matrigel for 18 h (top) or MDCK cells on plastic
(bottom) were treated with HGF (50 ng/ml), hES monomer (3,500 nM), hES dimer (50 nM), or c18 NC1/hES trimer (50 nM) for 24 h
and photographed. Top, magnification 3200; bottom, 3100. Note complete absence of HGF response in HUVECs on Matrigel and
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kidney, paralleling collagen IV (Muragaki et al., 1995;
Musso et al., 1998; Saarela et al., 1998). Furthermore, the
clinical spectrum of Knobloch syndrome has implicated
collagen XVIII in diverse functions including neural tube
and/or scalp closure and maintenance of retinal structure
(Sertie et al., 2000), whereas cle-1 mutations in C. elegans
produce neuronal migration deficits (Ackley et al., 2001).
The ability of c18 NC1 or ES dimer to induce motility of
nonendothelial cell types was evaluated using PC12 pheo-
chromocytoma cells or 293T embryonic kidney cells plated
on Matrigel. Under these plating conditions, these cell
lines aggregated into multicellular collections (Fig. 5).
However, culture with ES dimer or c18 NC1 produced a
dispersed phenotype resembling plastic-plated cells rather
than forming multicellular aggregates, with ES monomer
completely inactive (Fig. 5). We have also observed simi-
lar results with NIH 3T3 fibroblasts and Lewis lung carci-
noma (data not shown). The trimeric c18 NC1 domain can
thus modulate the matrix-regulated motility and morpho-
genesis of numerous cell types and possesses considerably
broader tissue tropism than described for monomeric c18
ES domains (O’Reilly et al., 1997; Dhanabal et al.,
1999a,b; Yamaguchi et al., 1999).
Functional Distinction between the c18 and
HGF/MSP Motogens
The motile response to c18 NC1 resembled the activity of
the motogens HGF/scatter factor and macrophage stimu-
latory protein (MSP) (Gherardi and Stoker, 1991) which
regulate motility, morphogenesis, proliferation, and apop-
tosis. HGF and MSP have been termed “scatter factors”
because of their ability to induce motility and disaggrega-
tion of cells from acini formed on tissue culture plastic
(Gherardi and Stoker, 1991). The motogenic activity of
HGF correlates with in vivo augmentation of the meta-
static potential of tumorigenic lines (Jeffers et al., 1996a,b)
and with essential roles in the developmental migration of
muscle and neural crest precursors (Tamagnone and Co-
moglio, 1997). Additionally, HGF possesses morphogenic
activities which promote angiogenesis and tubulogenesis
both in vivo and in vitro (Grant et al., 1993; Tamagnone
and Comoglio, 1997).
Given the ability of HGF and c18 NC1 to induce motil-
ity and disaggregation of cells, effects on HUVEC tube
formation were compared. In contrast to c18 NC1 and ES
dimers, HGF did not promote motility of HUVECs (Fig.
6, top), despite abundant expression of the HGF receptor
c-met on HUVECs (Bussolino et al., 1992). On the other
hand, HGF potently disaggregated and scattered MDCK
(Fig 6, bottom) and HepG2 cells (data not shown) on plas-
tic, whereas NC1 and ES dimers were inactive under these
conditions (Fig. 6, bottom). MSP was also unable to disag-
gregate HUVEC tubules on Matrigel (data not shown).
Notably, HGF stimulates tube formation in collagen ma-
trices (Bussolino et al., 1992; Grant et al., 1993; Tamag-
none and Comoglio, 1997), as opposed to the antitubulo-
genic effects of c18 NC1 described here for endothelial
cells. The collagen XVIII NC1 domain therefore defines a
novel class of motogenic factor which strictly requires the
presence of ECM and is both structurally and functionally
distinct from HGF/MSP.
Figure 7. Blockade of the MAPK pathway
antagonizes c18-induced motility. (A) Stimu-
lation of MAPK phosphorylation by c18
NC1 and ES dimer. HUVECs on Matrigel in
the presence or absence of ES monomer
(3,000 nM), ES dimer (50 nM), or c18 NC1
(50 nM), and harvested and analyzed by
Western blotting using anti–phospho-MAPK
antisera after 24 h. (B) Time kinetics of
MAPK activation by ES dimer. HUVECs on
Matrigel for 16 h were stimulated with ES
dimer (50 nM) or ES monomer (3,000 nM)
for the indicated times, followed by harvest
and Western blotting with anti–phospho-
MAPK antisera. Stimulation was measured
by densitometry and represents the average
of three independent experiments. Similar
results were observed for NC1. (C and D)
Inhibition of ES dimer–induced motility by
the MEK inhibitor PD98056 but not the p38 inhibitor SB203580. HUVECs were seeded on Matrigel for 16 h followed by 60-min prein-
cubation with or without PD98056 or SB203580 (50 mM), followed by treatment with hES dimer (50 nM) for 12 h, and then harvest for
anti–phospho-MAPK Western blot (C) or phase–contrast microscopy (D) (magnification 340).Kuo et al. Collagen XVIII Motogenic Activity 1241
Collagen XVIII NC1 Requires MAPK Activation for 
Induction of Motility
The MAPK pathway regulates numerous aspects of cell
growth, differentiation, and responses to extracellular
stimuli (Schaeffer and Weber, 1999) and is required for
HGF-stimulated motility (Potempa and Ridley, 1998).
On ECM substrata, only c18 NC1 and ES dimer, and not
ES monomer, activated MAPK. MAPK induction was
Figure 8. Motogenic activity of c18 NC1 requires rac and cdc42. (A) Inhibition of c18-stimulated motility by C. difficile toxin B. HUVECs
on Matrigel for 12 h were preincubated with or without C. difficile toxin B (50 ng/ml) for 4 h and treated with hES monomer (3,000 nM),
hES dimer (50 nM), or c18 NC1 (50 nM) for 16 h, then photographed under phase–contrast (magnification 3200). Trypan blue staining of
these cultures revealed ,5% toxicity from the toxin treatment. Cell-rounding characteristic of rho inhibition is present in 1toxin
panels. (B) Inhibition of c18 NC1-stimulated motility by adenovirus-encoded DN alleles of rac and cdc42. Top, HUVEC tubules pre-
viously infected with adenovirus encoding racDN, rhoDN, or cdc42DN were treated with hES dimer (75 nM) and photographed
(magnification 3200). Strong inhibition of motility by racDN and cdc42DN is present. RhoDN was ineffective at blocking scatter, al-
though cell-rounding characteristic of rho inhibition was observed. Bottom, Parallel cultures were treated identically and processed
for immunofluorescence using anti-myc epitope tag (rac, cdc42) or anti-rho (rhoDN and dimer alone), revealing .95% infection
with racDN, rhoDN, and cdc42DN.The Journal of Cell Biology, Volume 152, 2001 1242
first detectable within 90 min, paralleling the onset of cel-
lular motility, and persisted for .24 h, in contrast to
monomer or untreated cultures in which basal MAPK ac-
tivity declined to undetectable levels at that time (Fig. 7,
A and B). These persistent activation kinetics are reminis-
cent of signaling via the DDR collagen receptor kinases,
which require 18 h of exposure for maximum induc-
tion of phosphotyrosine (Vogel, 1999), and HGF, which
also stimulates prolonged (.16 h) MAPK activation (Po-
tempa and Ridley, 1998). Stimulation of tyrosine phos-
Figure 9. Autoregulatory inhibition of c18
NC1 by the cleavage product ES monomer.
(A) ES monomer inhibits motility induced
by c18 NC1 or hES dimer. Left panels,
HUVEC tubules on Matrigel for 12 h were
treated with ES dimer (50 nM) or NC1/ES
trimer (75 nM) for 24 h after 30-min prein-
cubation with human ES monomer (3,000
nM) as appropriate, followed by phase–
contrast microscopy (magnification 340).
B, PC12 cells were plated on Matrigel in
the presence of ES dimer (50 nM) or NC1/
ES trimer (75 nM) for 20 h with or without
30-min preincubation with human ES
monomer (3,000 nM) as appropriate, fol-
lowed by phase–contrast microscopy
(magnification 3200). Similar results
were obtained with treatment with factors
after 12–16-h culture on Matrigel. (C)
Dose-dependent reversal of c18 NC1 inhi-
bition of HUVEC tube formation by ES
monomer. Increasing concentrations of
hES monomer were added to freshly
seeded HUVECs on Matrigel, followed
after 30 min by addition of c18 NC1 (50 or
200 nM) and quantitation of tube forma-
tion after 16 h. Higher concentrations of
ES monomer were required to reverse in-
hibition by 200 nM as opposed to 50 nM
NC1. (D) Stimulation of MAPK by c18
NC1 or ES dimer is inhibited by ES
monomer. HUVEC tubules on Matrigel
for 16 h were preincubated with 3,000 nM
hES monomer or PBS for 30 min as ap-
propriate, followed by stimulation with
hNC1 or hES dimer (50 nM) for 24 h and
Western blotting with anti–phospho-
MAPK antibody.Kuo et al. Collagen XVIII Motogenic Activity 1243
phorylation in HUVECs on Matrigel by c18 derivatives
also requires ES domain oligomerization (LaMontagne,
K.R., and C.J. Kuo, unpublished observations).
Preincubation of HUVEC tubules with the MAPK ki-
nase (MEK) inhibitor PD98056 strongly inhibited the abil-
ity of ES dimer to elicit cellular motility and MAPK acti-
vation in parallel (Fig. 7, C and D), indicating that the
MAPK pathway is essential for the c18 motile response. In
contrast, inhibition was not observed with SB203580,
which inhibits the stress-activated p38 MAPK, indicating a
selective requirement for the mitogenic MAPK pathway
represented by MEK and MAPK, and not the stress re-
sponse MAPK pathway represented by p38 and MKK3/4
(Fig. 7, C and D).
Inhibition of ES Oligomer-mediated Motility by 
Blockade of rac and cdc42
During NC1- and ES dimer-induced motility, rapidly de-
marginating cells appeared as early as 1–2 h with promi-
nent lamellipodia, filopodia, and stress fibers (Fig. 2
A; see also videomicroscopy at Fig. 3 C and http://
www.jcb.org./cgi/content/full/152/6/1233/DC1). Given the
regulation of these structures by rho-family G proteins
(Hall, 1998), we used C. difficile toxin B which glucosy-
lates and inhibits rho-family GTPases. Preincubation of
preformed HUVEC tubules with C. difficile toxin B pro-
duced complete blockade of ES dimer– and NC1-induced
scatter (Fig. 8 A), with trypan blue staining confirming
.95% cell viability (data not shown). To evaluate the po-
tential role of individual rho-family GTPase family mem-
bers, preformed HUVEC tubules were infected with ade-
noviruses encoding DN alleles of rac, rho, and cdc42
(Kalman et al., 1999). Strong inhibition of ES dimer–
induced motility was observed with infection with racDN
and cdc42DN viruses (Fig. 8 B). In contrast, no blockade
was obtained with a rhoDN adenovirus, although cell
rounding characteristic of stress fiber loss was observed
(Fig. 8 B). Immunofluorescence revealed .95% infec-
tion of endothelial cells (Fig. 8 B, bottom). These results
suggest that rac and cdc42 mediate the motile response to
ES oligomers, and parallel findings that HGF-induced
scatter is inhibited by racDN but not rhoDN (Ridley et
al., 1995).
Autoregulatory Inhibition of c18 NC1-stimulated 
Motility by ES Monomer
Collagen XVIII undergoes proteolytic processing in vivo
by cathepsin-L and elastase-like proteases (Wen et al.,
1999; Felbor et al., 2000) to generate both NC1 trimers and
ES domain monomers (Sasaki et al., 1998; Wen et al.,
1999). Because of the clear oligomerization dependence of
c18 motogenic activity, we investigated whether the physi-
ologic cleavage product ES monomer might inhibit motil-
ity induced by the NC1 ES trimer. Although treatment of
HUVECs or PC12 cells with NC1 or ES dimer resulted in
characteristic cell motility, pretreatment with 40-fold mo-
lar excess of ES monomer before ES oligomer treatment
strongly inhibited motogenic activity (Fig. 9, A–C). Identi-
cal inhibition of motility was also observed with human ES
monomer produced in yeast or murine ES monomer pro-
duced in baculovirus (data not shown). In parallel, ES
monomer pretreatment also abrogated c18 NC1- and ES
dimer–induced MAPK activation (Fig. 9 D) and tyrosine
phosphorylation (LaMontagne, K.R., and C.J. Kuo, un-
published observations). These data suggest the possibility
of negative autoregulation of endogenous c18 NC1 activity
mediated by in vivo proteolytic release of monomeric ES
domains and reiterate the requirement for ES domain oli-
gomerization.
Discussion
An Evolutionarily Conserved ECM Collagen as 
Motogen and Morphogen
The ECM regulates cellular morphogenesis by serving as a
passive structural support, a repository for growth factors,
and a ligand for cellular receptors such as integrins and
DDR tyrosine kinases (Giancotti and Ruoslahti, 1999; Vo-
gel, 1999). The collagen XV/XVIII family has been par-
ticularly interesting because of a COOH-terminal ES
domain not present in other collagens, and strong evolu-
tionary conservation, being one of only two verterbrate
basement membrane collagens conserved in C. elegans
and Drosophila (Hutter et al., 2000; Hynes and Zhao,
2000). Despite this ancestral presence in invertebrate spe-
cies, the physiologic functions of the XV/XVIII collagens
have remained undefined.
In this work, we describe that the ES region of collagen
XVIII functions as an effector domain regulating ECM-
dependent motility and morphogenesis of numerous cell
types. The composite nature of c18 in both vertebrates and
C. elegans, with NH2-terminal frizzled/wingless receptor
(vertebrate) or unc-40/netrin receptor (C. elegans) do-
mains, and COOH-terminal ES/motogen domains, could
certainly facilitate sophisticated and modular control of
cell migration by ECM during development and morpho-
genesis (Muragaki et al., 1995; Rehn et al., 1998; Ackley et
al., 2001). The inactivity of the homologous c15 ES domain
in dimeric and trimeric forms suggests a highly specific
function for c18 (Fig. 4) and is consistent with structural
differences between c15 and c18 NC1 domains (Sasaki et
al., 2000), although certainly other contexts may be discov-
ered in which c15 NC1 exhibits motogenic activity.
Motility Induced by Collagen XVIII NC1 Requires ES 
Domain Oligomerization
The c18 motogenic activity localizes to and absolutely re-
quires oligomerization of the ES domain based on several
lines of evidence. The COOH-terminal ES domain is obli-
gately trimerized in c18 via intrinsically triple helical col-
lagen structure and a redundant trimerization motif within
NC1 (Muragaki et al., 1994; Rehn and Pihlajaniemi, 1994;
Sasaki et al., 1998). The motogenic activity of the NC1 do-
main, representing an ES trimer, is reproduced by ES
dimers in the form of either Fc-ES or the ES(Q7®C7)
dimer. In turn, the activity of the ES(Q7®C7) dimer (IC50
10 nM) contrasts starkly with the inactivity of monomeric
ES domains which differ by essentially a single disulfide
bond (inactive at 3,000 nM, the highest concentration
tested). The stimulation of motility by the pure ES domain
dimer but not ES monomers clearly demonstrates that ES
oligomerization is both necessary and sufficient for moto-
genic activity (Fig. 3). This oligomerization requirement is
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but not ES monomers, to activate MAPK and tyrosine
phosphorylation on ECM (Figs. 7 and 9; LaMontagne,
K.R. and C.J. Kuo, unpublished observations).
Theoretically, oligomerization could facilitate c18 action
upon specific cellular and/or matrix receptors. On the one
hand, ES domain oligomerization could promote cross-
linking of transmembrane signaling molecules, such as in-
tegrins, by analogy to growth factor receptors. On the
other hand, NC1 ES trimers bind with 100–200-fold higher
affinity than ES monomers to ECM components such as
laminin/nidogen, perlecan, and sulfatides (Sasaki et al.,
1998) and could regulate the association of matrix compo-
nents with cellular receptors. We have observed ES do-
main binding to both membrane and matrix components,
as has been described for FGF, VEGF, HGF, and Wing-
less (Yayon et al., 1991; Park et al., 1993; Reichsman et al.,
1996; Binari et al., 1997; Chirgadze et al., 1999) and are ac-
tively investigating these two potential sites of action.
Comparison and Contrast between the c18 and
HGF/MSP Motogens
As described here, collagen XVIII represents a novel mo-
togen both structurally and functionally distinct from the
archetypal HGF/MSP scatter factor class. The triple heli-
cal structure of collagen XVIII, with its three associated
globular ES domains, little resembles the kringle struc-
tures of the plasminogen-like HGF and MSP proteins
(Tamagnone and Comoglio, 1997). HGF induces motile
scatter responses on plastic within 12 h but promotes tube
formation and branching morphogenesis in collagen gels
over a 4–6-d period (Tamagnone and Comoglio, 1997). In
contrast, c18 NC1 does not promote disaggregation on
plastic but induces rapid motility and disassembly on
Matrigel as rapidly as 2 h, conditions in which HGF and
MSP are inactive. Despite obvious differences in structure
and context of activity, the motile responses induced by
c18 and HGF exhibit similar downstream effector require-
ments for MAPK, rac, and cdc42 but not rho (Ridley et al.,
1995; Potempa and Ridley, 1998; Figs. 7 and 8). The dis-
tinct activities of c18 and HGF suggest the potential to
provide regulatory complexity during developmental mor-
phogenesis and tissue remodeling.
Inhibition of ECM-induced Morphogenesis by the 
Collagen XVIII NC1 Domain
Culture of endothelial and nonendothelial cells on rich
ECM preparations such as Matrigel is associated with pro-
nounced alterations in cellular morphogenesis and adhe-
sion. In the case of endothelial cells, these morphologic
changes resemble the formation of vascular “tubes” with
recapitulation of angiogenic processes including branch-
ing, migration, and differentiation (Folkman and Hauden-
schild, 1980; Grant et al., 1991). On the other hand, the sig-
nificance of tube-like structures and aggregates formed by
nonendothelial cell types such as fibroblasts and epithelial
cells on ECM preparations is less clear. As described here,
the c18 NC1 domain potently reverts ECM-induced mor-
phologic changes of both endothelial and nonendothelial
cell types, with cells assuming a morphology resembling
cells plated on plastic. It thus seems likely that the c18
NC1 domain represents a previously unsuspected inhibitor
of ECM-induced morphogenesis. Additionally, the long-
described aggregation and morphogenetic responses of
cells to complex ECM preparations such as Matrigel could
reflect a property which is not endothelial specific but
rather represents a highly conserved, c18 NC1-sensitive re-
sponse to ECM component(s) exhibited by diverse endo-
thelial and nonendothelial cell types. These ECM compo-
nents likely do not include collagen I or fibrin in isolation,
since we have not observed effects of c18 NC1 against cells
cultured on gels composed of these purified proteins (data
not shown).
Negative Autoregulation by the Cleavage Product
ES Monomer
The monomeric ES domain of c18 has been reported to be
an antiangiogenic agent inhibiting endothelial cell prolif-
eration and migration and inducing endothelial apoptosis
in systems not using the ECM (O’Reilly et al., 1997; Dha-
nabal et al., 1999a,b; Yamaguchi et al., 1999; Dixelius et
al., 2000). Here, we describe that the trimeric precursor
c18 NC1 exhibits motility-inducing and morphogenic ac-
tivities which are distinct from and in fact antagonized by
the monomeric ES domain. Indeed, although c18 NC1
promotes motility, scatter, and MAPK induction, these ac-
tivities are not exhibited by and are actually inhibited by
ES monomer on ECM substrata (Fig. 9). This antagonistic
relationship is potentially consistent with our inability to
detect responses attributed to ES monomer such as inhibi-
tion of proliferation or apoptosis induction after c18 NC1
treatment (O’Reilly et al., 1997; Dhanabal et al., 1999a,b;
Yamaguchi et al., 1999; Dixelius et al., 2000) (although
these reports did not utilize ECM substrata) and reports in
which ES monomers actually enhance rather than inhibit
endothelial tube formation (Dixelius et al., 2000). Addi-
tionally, we have not observed significant antiangiogenic
activity of c18 NC1 or ES dimers in corneal micropocket
assays, in contrast to reports with ES monomers (Dixelius
et al., 2000). It has been reported that both ES monomers
and NC1 inhibit HUVEC migration in VEGF-based tran-
swell chambers (although these assays did not employ ma-
trix substrata, required endothelial cells of defined passage
number, and required preincubation with factor [Yamagu-
chi et al., 1999]). Notably, an opposing relationship be-
tween ES monomer and trimeric c18 has been suggested
based on purely structural considerations (Schuppan et al.,
1998).
Both full-length c18 and fragments corresponding to
NC1 and ES exist in both tissues and serum (Standker et
al., 1997; Sasaki et al., 1998; John et al., 1999; Wen et al.,
1999). Given the description of processing proteases which
cleave monomeric ES from trimeric c18/NC1 (Wen et al.,
1999; Felbor et al., 2000), the in vivo proteolytic cleavage
of ES could constitute an autoregulatory feedback loop
which terminates and actively opposes the activity of c18.
Evolutionarily Conserved Oligomerization-dependent 
Motility Regulation by the Collagen XVIII
NC1/ES Domain
Among the twenty-odd vertebrate collagen genes, only
collagen IV and collagen XV/XVIII are conserved within
the  C. elegans and Drosophila genomes (Prockop andKuo et al. Collagen XVIII Motogenic Activity 1245
Kivirikko, 1995; Hutter et al., 2000), consistent with an
evolutionarily conserved function of c18. Ackley et al.
(2001) in this issue characterize the C. elegans collagen
XVIII homologue cle-1 which exhibits numerous struc-
tural similarities with vertebrate collagen XVIII, including
conserved intron/exon boundaries, a triple helical collage-
nous domain, trimeric properties of the NC1 domain, and
45% amino acid identity in the ES domain. Notably, neu-
ronal migration and axonal pathfinding deficits in cle-1
mutants lacking the COOH-terminal ES domain are res-
cued only by trimeric CLE-1 NC1 and not by monomeric
CLE-1 ES domains. Similarly, neuronal motility stimu-
lated by wild-type trimeric CLE-1 is dominantly inhibited
by overexpression of the physiologic cleavage product ES
monomer but not by trimeric CLE-1 NC1, consistent with
oligomerization dependence and negative autoregulation.
The extensive structural and mechanistic parallels be-
tween C. elegans  cle-1 and vertebrate c18 suggest that
collagen XVIII homologues throughout evolution regu-
late cell motility in a manner both dependent on ES do-
main oligomerization and negatively autoregulated by ES
monomers. This convergence of function in organisms as
diverse as vertebrates and C. elegans should provide a
mechanistic foundation for elaborating the roles of c18 in
motility-dependent processes such as angiogenesis, neuro-
genesis, branching morphogenesis, and metastasis in both
vertebrate and invertebrate species.
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